A Nevada woman is suing Merck & Co. alleging the company’s shingles vaccine Zostavax caused her to suffer chronic high blood pressure, eye injury, headaches and dizziness. Her complaint was filed in Philadelphia’s Court of Common Pleas.
Borja Bentley claims that the patient information sheet, safety label, and prescribing information that accompanied the shingles vaccine did not warn of the risk of viral infection. Yet, since the vaccine was approved by the Food and Drug Administration (FDA) to prevent shingles in people age 60 and older, numerous reports of viral infections have been reported.
“Despite this information and the potential correlation between being administered the Zostavax vaccine and developing an infection within a relatively short period of time, leading to the development of shingles or varicella-zoster virus pneumonia, Merck failed to properly address and provide this information both to patients and the medical providers prescribing the vaccine,” Bentley’s complaint states.
Bentley claims she received the vaccine in November 2014 and shortly afterward suffered a headache, dizziness and blurred vision. Since then, she said she continues to experience bouts of high blood pressure, headaches and dizziness, as well as injury to her right eye.
Bentley claims that Merck manufactured and marketed the vaccine but failed to warn consumers of the infection risks. She claims that several scientific and medical journals contain articles that question the safety of the vaccine.
Bentley is suing for negligence, design defect, failure to warn, breaches of express and implied warranties, fraudulent and negligent misrepresentation and unjust enrichment. She is also seeking punitive damages.
Bentley’s case is the first alleging injuries from Zostavax.